The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis

Clinical Cardiology

Volumn 25, Issue 4, 2002, Pages 174-180

  Qi, Wei ^a   Mathisen, Per ^a   Kjekshus, John ^a   Simonsen, Svein ^a   Endresen, Knut ^a   Bjørnerheim, Reidar ^a   Hall, Christian ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Aortic stenosis; Aortic valve area; Atrial natriuretic factor; Atrial pressure; Brain natriuretic peptide; Left ventricular hypertrophy

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; PROTEIN PRECURSOR;

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

AGED; AORTIC VALVE STENOSIS; ATRIAL NATRIURETIC FACTOR; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; NATRIURETIC PEPTIDE, BRAIN; PROTEIN PRECURSORS; PULMONARY WEDGE PRESSURE; VENTRICULAR PRESSURE;

EID: 0036201748     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960250408     Document Type: Article

References (22)

1. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
2. Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides
3. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor
4. NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-life
5. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: An important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine
6. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
7. Aortic stenosis
8. Brain natriuretic peptide in patients with aortic stenosis: Comparison with N-terminal proatrial natriuretic peptide and atrial natriuretic peptide
9. Cardiac output measured by Doppler echocardiography in patients with aortic prosthetic valves
10. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
11. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man
12. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog
13. Degradation and distribution of brain natriuretic peptide in porcine tissues
14. Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure
15. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT- PROBNP): A new marker of cardiac impairment
16. Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humans
17. Pulmonary extraction and left atrial secretion of atrial natriuretic factor during cardiopulmonary bypass surgery
18. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: A prospective two-dimensional echocardiographic study
19. Time course of regression of left ventricular hypertrophy after aortic valve replacement
20. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement
21. Regression of left ventricular mass one year after valve replacement for severe aortic stenosis is dependent on prosthetic valve size: A three-dimensional echocardiographic study
22. The problem of valve prosthesis-patient mismatch